JNJ
JOHNSON&JOHNSON
Health Care·Pharmaceuticals·UNITED STATES
$267.37
MCap $644.3B
as of 2026-08-20
Total
B4w
Fund
D2w
Quant
A8w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.43
Sentiment 79.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$267.37
Adaptive Mean
$269.67
-2.30 vs mean
Adaptive σ
2.67
MIDOS BB
$264.33 – $275.02
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.10
ROE
25.7%
Z +0.69
Rev Gr
6.6%
Z -0.22
EPS Gr
-0.9%
Z +0.27
OPM Gr
0.1%
Z -0.40
FCF Yld
2.6%
Z +0.26
EPS Surp
0.0%
Z -0.08
EPS 3mo Δ
-13.4%
Z +0.17
Fwd P/E
21.86
Z —
PEGY
0.11
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
16.18
Q6M
5.75
Q12M
14.00
MA 30/100
1.069
Bullish (MA30 > MA100)
α (Jensen)
0.6922
β (12M)
-0.18
σ (12M)
0.186
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
68%
Q Percentile
100%
Divergence
-31.4
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
-1.1
RS Pctl
60%
RS Decile
D6
Persistence
4w
at grade B
Options / OI Analysis
as of 2026-08-21
OI Center
$245.75
-9.6% from spot
Max Pain
$257.50
PCR (OI)
0.66
neutral
Skew
-0.49
OI Composite
-1
neutral
Direction
strong_bearish